“Clinical comparison in the remote management of bronchial asthma during the COVID-19 pandemic between two controller therapies: Fluticasone and beclomethasone”, Acta Med Peru, vol. 40, no. 4, Feb. 2024, doi: 10.35663/amp.2023.404.2692.